Please try another search
aXichem AB, a biotechnology company, engages in the development of natural analogue ingredients in Sweden. It offers aXivite, a natural analogue capsaicin solution for a range of dietary health applications; aXiphen-bio, a bio-repellent for antifouling protection for vessels and marine installations, pest control in agriculture and forestry, and pest control for cable installations in buildings and underground cables; and aXiphen-feed, a solution for enhanced health for chickens, hens, pigs, and piglets. The company was founded in 1999 and is based in Malmö, Sweden.
Name | Age | Since | Title |
---|---|---|---|
Jan Gustavsson | 76 | 2017 | Independent Chairman of the Board |
Gunilla Savring | 61 | 2014 | Director of IR & Director |
Torsten Helsing | 66 | 2007 | CEO & Director |
Jorn H. Berthelsen | 74 | 2017 | Independent Director |
Edward Van den Elsen | 55 | 2022 | Independent Director |
Christian Mansson | 43 | 2023 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review